Characterization of NAD:arginine ADP-ribosyltransferases
Overview
Authors
Affiliations
NAD:arginine mono-ADP-ribosyltransferases catalyze the transfer of ADP-ribose from NAD to the guanidino group of arginine on a target protein. Deduced amino acid sequences of one family (ART1) of mammalian ADP-ribosyltransferases, cloned from muscle and lymphocytes, show hydrophobic amino and carboxyl termini consistent with glycosylphosphatidylinositol (GPI)-anchored proteins. The proteins, overexpressed in mammalian cells transfected with the transferase cDNAs, are released from the cell surface with phosphatidylinositol-specific phospholipase C (PI-PLC), and display immunological and biochemical characteristics consistent with a cell surface, GPI-anchored protein. In contrast, the deduced amino acid sequence of a second family (ART5) of transferases, cloned from murine lymphoma cells and expressed in high abundance in testis, displays a hydrophobic amino terminus, consistent with a signal sequence, but lacks a hydrophobic signal sequence at its carboxyl terminus, suggesting that the protein is destined for export. Consistent with the surface localization of the GPI-linked transferases, multiple surface substrates have been identified in myotubes and activated lymphocytes, and, notably, include integrin alpha subunits. Similar to the bacterial toxin ADP-ribosyltransferases, the mammalian transferases contain the characteristic domains involved in NAD binding and ADP-ribose transfer, including a highly acidic region near the carboxy terminus, which, when disrupted by in vitro mutagenesis, results in a loss of enzymatic activity. The carboxyl half of the protein, synthesized as a fusion protein in E. coli, possessed NADase, but not ADP-ribosyltransferase activity. These findings are consistent with the existence at the carboxyl terminus of ART1 of a catalytically active domain, capable of hydrolyzing NAD, but not of transferring ADP-ribose to a guanidino acceptor.
ARH Family of ADP-Ribose-Acceptor Hydrolases.
Ishiwata-Endo H, Kato J, Yamashita S, Chea C, Koike K, Lee D Cells. 2022; 11(23).
PMID: 36497109 PMC: 9738213. DOI: 10.3390/cells11233853.
Identification of a 6-gene signature predicting prognosis for colorectal cancer.
Zuo S, Dai G, Ren X Cancer Cell Int. 2019; 19:6.
PMID: 30627052 PMC: 6321660. DOI: 10.1186/s12935-018-0724-7.
Ling F, Tang Y, Li M, Li Q, Li X, Yang L Oncotarget. 2017; 8(42):72773-72787.
PMID: 29069825 PMC: 5641168. DOI: 10.18632/oncotarget.20347.
Yang L, Gao Z, Hu L, Wu G, Yang X, Zhang L J Biol Chem. 2015; 291(8):3905-17.
PMID: 26683373 PMC: 4759170. DOI: 10.1074/jbc.M115.705830.
Tang Y, Li M, Wang Y, Threadgill M, Xiao M, Mou C Am J Cancer Res. 2015; 5(2):498-513.
PMID: 25973293 PMC: 4396040.